What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 59 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 71%

United Kingdom Headlines News

United Kingdom Latest News,United Kingdom Headlines

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations? medrxivpreprint UniofOxford SARSCoV2 COVID19 Vaccination Vaccine Efficacy Booster

By Shanet Susan AlexAug 2 2022Reviewed by Aimee Molineux In a recent study posted to the medRxiv* preprint server, scientists compared the effectiveness of the severe acute respiratory syndrome coronavirus 2 BNT162b2 and mRNA-1273 vaccine booster doses in England.

About the study In the current study, on account of National Health Service England, the researchers used the OpenSAFELY-TPP database to match adults who received the SARS-CoV-2 mRNA-1273 or BNT162b2 vaccine on vaccination date, age, primary vaccine course, and other factors.

Results Overall, the study results showed that during the research period, 10,139,268 people registered at a TPP practice had a COVID-19 booster shot with either mRNA-1273 or BNT162b2 , with 6,264,525, i.e., 86.5%, and 6,264,525, i.e., 87.1%, eligible for matching. Compared to mRNA-1273 booster recipients, eligible BNT162b2 booster recipients were typically more deprived, older, and more likely to have a history of clinical conditions.

Less than one in 3,800 booster recipients were hospitalized with COVID-19, and less than one in 100,000 died with COVID-19 as a contributing or underlying cause. Severe COVID-19 disease was extremely uncommon up to 12 weeks post-booster vaccination. Regardless of clinical vulnerability, age, or evidence of past infection, the relative efficacy of mRNA1273 versus BNT162b2 against COVID-19 hospitalization was comparable.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CDC study describes safety profile of second mRNA COVID boosterThe CDC investigates the safety profile of a fourth dose of mRNA-based COVID-19 vaccines in people aged 50 years and older.
Source: NewsMedical - 🏆 19. / 71 Read more »

Reduced severity of COVID-19 in pregnant women during the Omicron waveA new study assesses the clinical outcomes of COVID-19 in pregnant women to determine whether Omicron and vaccination status impacted disease severity.
Source: NewsMedical - 🏆 19. / 71 Read more »

Is cannabidiol effective against COVID-19?Is cannabidiol effective against COVID-19? Coronavirus Disease COVID Antibodies AntiInflammatory Asthma Cannabidiol Cannabinoid Cannabis LiebertPub LMU_Muenchen
Source: NewsMedical - 🏆 19. / 71 Read more »

Good Morning Britain's Kate Garraway gives an update on husbandHer husband has been struggling with long term health problems due to Covid-19
Source: nottslive - 🏆 96. / 52 Read more »

Changes in Smoking Cessation–Related Behaviors During the COVID-19 PandemicThis cross-sectional study compares prevalence of past-year quit attempts and sales volumes of nicotine replacement therapy before vs during the COVID-19 pandemic among US adult smokers.
Source: medical_xpress - 🏆 101. / 51 Read more »

Study finds negative impact of COVID-19 pandemic on mental health status in low and middle income countriesStudy finds negative impact of COVID-19 pandemic on mental health status in low and middle income countries medrxivpreprint Yale VUamsterdam SARSCoV2 COVID19 Pandemic MentalHealth
Source: NewsMedical - 🏆 19. / 71 Read more »